Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Question

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Dec 11, 2023 6:51pm

180 Views

Post# 35778905

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Question

I checked and at the close today there was a bid for 2 million shares on the nasdaq at 1.30 U.S. dollars so for now someone has set the floor or just playing games with everyone.
This was confirmed with a call to cibc and 20,000 lots at 100 per lot which is 2 million shares.
Big time games being played at our expense.

$1.31 USD
Dec 11, 2023 4:00PM ET

Down -0.09
Down -6.43%

Bid
$1.30
bid lots
x20,000

Ask
$1.48
ask lots
x350

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing